Live Breaking News & Updates on News ratings for gilead sciences daily

Stay informed with the latest breaking news from News ratings for gilead sciences daily on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in News ratings for gilead sciences daily and stay connected to the pulse of your community

Gilead Sciences (NASDAQ:GILD) Issues FY 2024 Earnings Guidance

Gilead Sciences (NASDAQ:GILD – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 3.450-3.850 for the period, compared to the consensus earnings per share estimate of 3.670. The company issued revenue guidance of $27.1 billion-$27.5 billion, compared to the consensus revenue […]

Canada , United-states , Complera-eviplera , Merdad-parsey , Nasdaq , Morgan-stanley , Royal-bank , Gilead-sciences-stock , Gilead-sciences , Gilead-sciences-dividend-announcement , News-ratings-for-gilead-sciences-daily , Gilead-sciences-inc

Gilead Sciences, Inc. (NASDAQ:GILD) Declares $0.77 Quarterly Dividend

Gilead Sciences, Inc. (NASDAQ:GILD) Declares $0.77 Quarterly Dividend
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Complera-eviplera , Merdad-parsey , Gilead-sciences-inc , Insider-transactions-at-gilead-sciences , Gilead-sciences-trading , Morgan-stanley , Nasdaq , Gilead-sciences , Dividend-history-for-gilead-sciences , News-ratings-for-gilead-sciences-daily , Get-free-report

Gilead Sciences (NASDAQ:GILD) Given New $85.00 Price Target at TD Cowen

Gilead Sciences (NASDAQ:GILD – Free Report) had its price target decreased by TD Cowen from $90.00 to $85.00 in a report released on Friday, Benzinga reports. TD Cowen currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on GILD. Wells Fargo & Company decreased their price target […]

United-states , Canada , Complera-eviplera , Merdad-parsey , Wells-fargo-company , Securities-exchange-commission , Gilead-sciences-announces-dividend , Wealth-management-group , Gilead-sciences , Needham-company , Royal-bank , Analyst-recommendations-for-gilead-sciences

Argonautica Private Wealth Management Inc. Has $3.08 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Argonautica Private Wealth Management Inc. Has $3.08 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Complera-eviplera , Merdad-parsey , Gilead-sciences-price-performance , Royal-bank , Gilead-sciences-inc , Quarter-for-gilead-sciences , Nasdaq , Needham-company , Tompkins-financial-corp , Argonautica-private-wealth-management-inc

Gilead Sciences, Inc. Declares Quarterly Dividend of $0.77 (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) announced a quarterly dividend on Thursday, April 25th, Zacks reports. Stockholders of record on Friday, June 14th will be paid a dividend of 0.77 per share by the biopharmaceutical company on Thursday, June 27th. This represents a $3.08 dividend on an annualized basis and a dividend yield […]

United-states , Merdad-parsey , Complera-eviplera , Needham-company , Insider-transactions-at-gilead-sciences , News-ratings-for-gilead-sciences-daily , Gilead-sciences-inc , Dividend-history-for-gilead-sciences , Gilead-sciences-stock-performance , Gilead-sciences , Nasdaq , Get-free-report

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Bahl & Gaynor Inc.

Bahl & Gaynor Inc. decreased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 13,390 shares of the biopharmaceutical company’s stock after selling 1,155 shares during the quarter. Bahl & Gaynor Inc.’s […]

United-states , Merdad-parsey , Complera-eviplera , Needham-company , Insider-transactions-at-gilead-sciences , Rakuten-securities-inc , News-ratings-for-gilead-sciences-daily , Fortitude-family-office , Gilead-sciences-stock-performance , Gilead-sciences , Gilead-sciences-announces-dividend , Financial-connections-group-inc

Gilead Sciences, Inc. Declares Quarterly Dividend of $0.77 (NASDAQ:GILD)

Gilead Sciences, Inc. Declares Quarterly Dividend of $0.77 (NASDAQ:GILD)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United-states , Merdad-parsey , Complera-eviplera , Insider-transactions-at-gilead-sciences , Wells-fargo-company , Gilead-sciences-price-performance , Dividend-history-for-gilead-sciences , Gilead-sciences-inc , News-ratings-for-gilead-sciences-daily , Gilead-sciences , Nasdaq , Morgan-stanley

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Bahl & Gaynor Inc.

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Bahl & Gaynor Inc.
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Merdad-parsey , Complera-eviplera , Financial-connections-group-inc , Gilead-sciences-announces-dividend , Gilead-sciences , Cantor-fitzgerald , Bahl-gaynor-inc , Gilead-sciences-inc , Quarter-for-gilead-sciences , Nasdaq , Tompkins-financial-corp

Gilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLC

Gilead Sciences (NASDAQ:GILD – Get Free Report)‘s stock had its “hold” rating reiterated by Needham & Company LLC in a research note issued on Friday, Benzinga reports. Other equities research analysts have also issued research reports about the stock. Truist Financial lowered shares of Gilead Sciences from a “buy” rating to a “hold” rating and […]

United-states , Merdad-parsey , Complera-eviplera , Gilead-sciences-inc , Securities-exchange-commission , Gilead-sciences-company-profile , Insider-transactions-at-gilead-sciences , Hermes-inc , Needham-company , Barclays , Gilead-sciences-stock-performance , Institutional-trading-of-gilead-sciences

Gilead Sciences (NASDAQ:GILD) PT Lowered to $74.00 at Royal Bank of Canada

Gilead Sciences (NASDAQ:GILD) PT Lowered to $74.00 at Royal Bank of Canada
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Complera-eviplera , Merdad-parsey , Gilead-sciences , Tompkins-financial-corp , Hedge-funds-weigh-in-on-gilead-sciences , Needham-company , Wells-fargo-company , Gilead-sciences-stock , Gilead-sciences-company-profile , Wealth-management-group